Primary |
Prophylaxis |
20.0% |
Antiallergic Therapy |
10.0% |
Constipation |
10.0% |
Drug Therapy |
10.0% |
Faeces Hard |
10.0% |
Laxative Supportive Care |
10.0% |
Lung Infection |
10.0% |
Smoking Cessation Therapy |
10.0% |
Vitamin Supplementation |
10.0% |
|
Transient Ischaemic Attack |
33.3% |
Pyrexia |
22.2% |
Abdominal Pain Upper |
11.1% |
Drug Toxicity |
11.1% |
Protein S Deficiency |
11.1% |
Throat Irritation |
11.1% |
|
Secondary |
Product Used For Unknown Indication |
58.9% |
Drug Use For Unknown Indication |
5.6% |
Constipation |
5.3% |
Eczema |
4.8% |
Schizophrenia |
3.2% |
Chemotherapy |
2.7% |
Pyrexia |
2.7% |
Atrial Fibrillation |
2.1% |
B Precursor Type Acute Leukaemia |
2.1% |
Medical Diet |
1.9% |
Obsessive-compulsive Disorder |
1.6% |
Cellulitis |
1.3% |
Hypertension |
1.3% |
Impulse-control Disorder |
1.3% |
Anxiety Disorder |
1.1% |
Benign Prostatic Hyperplasia |
0.8% |
Cardiac Failure Congestive |
0.8% |
Decreased Appetite |
0.8% |
Dehydration |
0.8% |
Nausea |
0.8% |
|
Death |
18.1% |
Drug Level Increased |
11.1% |
Toxicity To Various Agents |
11.1% |
Poisoning |
9.7% |
White Blood Cell Count Increased |
9.7% |
Diarrhoea |
6.9% |
Medication Error |
5.6% |
Overdose |
5.6% |
Accidental Exposure |
2.8% |
Respiratory Arrest |
2.8% |
Tremor |
2.8% |
Upper Respiratory Tract Infection |
2.8% |
Cardio-respiratory Arrest |
1.4% |
Depression |
1.4% |
Drug Interaction |
1.4% |
Drug Screen False Positive |
1.4% |
Drug Toxicity |
1.4% |
Drug Withdrawal Syndrome |
1.4% |
Flatulence |
1.4% |
Hallucination |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
38.1% |
Drug Use For Unknown Indication |
23.8% |
Pain |
5.5% |
Constipation |
5.0% |
Hypertension |
3.6% |
Prophylaxis |
3.0% |
Multiple Myeloma |
2.8% |
Sarcoma Metastatic |
2.5% |
Nausea |
2.0% |
Gastrooesophageal Reflux Disease |
1.6% |
Breast Cancer |
1.5% |
Diabetes Mellitus |
1.5% |
Depression |
1.5% |
Rheumatoid Arthritis |
1.2% |
Anxiety |
1.2% |
Rhabdomyosarcoma |
1.1% |
Non-small Cell Lung Cancer |
1.1% |
Osteoporosis |
1.0% |
Adverse Event |
0.9% |
Insomnia |
0.9% |
|
Vomiting |
15.9% |
Death |
7.4% |
Weight Decreased |
6.3% |
Urinary Tract Infection |
6.0% |
Pulmonary Embolism |
5.6% |
Pneumonia |
5.0% |
Renal Failure Acute |
4.9% |
White Blood Cell Count Decreased |
4.6% |
Pyrexia |
4.5% |
Tremor |
4.3% |
Thrombocytopenia |
4.1% |
Weight Increased |
4.1% |
Granulocytopenia |
3.9% |
Dyspnoea |
3.8% |
Type 2 Diabetes Mellitus |
3.7% |
Rash |
3.5% |
Somnolence |
3.2% |
Wheezing |
3.1% |
Renal Failure |
3.0% |
Small Intestinal Obstruction |
3.0% |
|